Take that, Big Tobacco, said The New York Times in an editorial. In an “enormous victory” for public health and a blow to the “rogue” tobacco industry’s ability to “inflict its harmful products on Americans with impunity," the Senate has cleared a bill that will finally let the Food and Drug Administration regulate tobacco products. The bill isn’t perfect—it prevents the FDA from banning cigarettes—but it will force cigarette makers to list ingredients, curtail marketing, and stop using most flavorings “used to lure first-time smokers.”
It’s true that cigarettes have killed tens of millions of smokers and cost the health-care system trillions of dollars, said Douglas McIntyre in 24/7 Wall Street, but “it is equally true that legislating control of people’s habits, especially the ones that they find pleasurable, is impossible”—just look at the “war on drugs.” The law also isn’t entirely bad for Big Tobacco: Once the FDA starts signing off on cigarette marketing and chemical additives, it will be harder to sue the cigarette makers.
It’s still the “most devastating legislative blow in history to Big Tobacco,” said Kate Pickert in Time, and all the major cigarette makers fought it—except Marlboro maker Philip Morris. With about half of U.S. smokers safely in its pocket, Philip Morris has reason to “lock in its market dominance” by limiting all cigarette advertising and promotion.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- What the Middle Ages can tell us about the GOP's big charity myth
- Why is the Pentagon stuffing caves in Norway full of tanks?
- The U.S. is about to sell weapons to Vietnam. That's bad news for China.
- 43 TV shows to watch in 2014
- The one thing the New Atheists get right about religion
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- Syrian women know how to defeat ISIS
- 3 horrific inaccuracies in Homeland's depiction of Islamabad
- The U.S. government is actually trouncing Ebola. When will it get credit?
- 6 things the happiest families all have in common
Subscribe to the Week